Search results

Immunovant IMVT reported top-line results from two phase III studies, known as the GO trials, evaluating batoclimab as an investigational treatment for adult patients with active, moderate-to-severe

Amgen AMGN announced positive top-line results from a late-stage study evaluating the subcutaneous (under the skin or SC) formulation of its blockbuster drug Tepezza (teprotumumab) in patients with

Broadridge Financial Solutions, Inc. BR is benefiting from its strong business model driven by higher recurring fee revenues. Its acquisitions and diverse offerings further support top-line growth

Omnicom OMC is benefiting from its diverse portfolio across domains, reducing reliance on single revenue streams and ensuring a stable top line. Its investments in IT, data, analytics and precision

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales

For the quarter ended March 2026, Delta Air Lines (DAL) reported revenue of $14.2 billion, up 1.1% over the same period last year. EPS came in at $0.64, compared to $0.46 in the year-ago quarter.

The multiline insurance industry has been benefiting from product diversification to lower concentration risk, ensure uninterrupted revenue generation and improve retention ratio. Increased adoption

Coherent Corp. COHR registered 33.5% year-over-year growth in its datacenter & communications segment’s revenues in the second quarter of fiscal 2026. This segment generated 72% of the top line, a

The Clorox Company CLX has been making constant innovations to enrich customer experience. The company concentrates on offering superior value to consumers by investing in its brands and making

• Shares of Delta Air Lines, Inc. (DAL) jumped 3.8% after the company reported first-quarter 2026 earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.61 per share.
• RPM

Shares of Iveda Solutions, Inc. IVDA have risen 1.4% since reporting results for 2025, in line with the S&P 500 index’s return. However, the stock has underperformed over the past month, declining

Old Dominion Freight Line, Inc. (ODFL) looks expensive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/E-F12M), ODFL is trading at a premium compared to the

Constellation Brands, Inc. STZ reported fourth-quarter fiscal 2026 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. The company’s sales and earnings declined year

Simulations Plus, Inc. SLP reported second-quarter fiscal 2026 adjusted earnings of 35 cents per share, surpassing the Zacks Consensus Estimate by 29%. The bottom line also compared favorably with

ImmunityBio’s IBRX shares rose 7%, following the release of better-than-expected preliminary product revenues for first-quarter 2026.

IBRX’s top line primarily comprises product sales from Anktiva